107 related articles for article (PubMed ID: 21418164)
1. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07).
Heading KL; Brockley LK; Bennett PF
Aust Vet J; 2011 Apr; 89(4):109-16. PubMed ID: 21418164
[TBL] [Abstract][Full Text] [Related]
2. Risk factors associated with the onset of lomustine-induced neutropenia in tumour-bearing dogs.
Treggiari E; Cossu G; Valenti P; Taylor A
Vet Comp Oncol; 2022 Sep; 20(3):577-586. PubMed ID: 35249267
[TBL] [Abstract][Full Text] [Related]
3. Frequency and Severity of Neutropenia Associated with Food and Drug Administration Approved and Compounded Formulations of Lomustine in Dogs with Cancer.
Burton JH; Stanley SD; Knych HK; Rodriguez CO; Skorupski KA; Rebhun RB
J Vet Intern Med; 2016; 30(1):242-6. PubMed ID: 26682700
[TBL] [Abstract][Full Text] [Related]
4. Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma.
Rassnick KM; Bailey DB; Malone EK; Flory AB; Kiselow MA; Intile JL
J Am Anim Hosp Assoc; 2014; 50(3):167-73. PubMed ID: 24659727
[TBL] [Abstract][Full Text] [Related]
5. Low apparent risk of CCNU (lomustine)-associated clinical hepatotoxicity in cats.
Musser ML; Quinn HT; Chretin JD
J Feline Med Surg; 2012 Dec; 14(12):871-5. PubMed ID: 22772480
[TBL] [Abstract][Full Text] [Related]
6. Toxicity associated with epirubicin treatments in a large case series of dogs.
Marrington AM; Killick DR; Grant IA; Blackwood L
Vet Comp Oncol; 2012 Jun; 10(2):113-23. PubMed ID: 22236353
[TBL] [Abstract][Full Text] [Related]
7. Comparison between symptomatic treatment and lomustine supplementation in 71 dogs with intracranial, space-occupying lesions.
Van Meervenne S; Verhoeven PS; de Vos J; Gielen IM; Polis I; Van Ham LM
Vet Comp Oncol; 2014 Mar; 12(1):67-77. PubMed ID: 22738696
[TBL] [Abstract][Full Text] [Related]
8. Survival times in dogs with presumptive intracranial gliomas treated with oral lomustine: A comparative retrospective study (2008-2017).
Moirano SJ; Dewey CW; Wright KZ; Cohen PW
Vet Comp Oncol; 2018 Dec; 16(4):459-466. PubMed ID: 29797768
[TBL] [Abstract][Full Text] [Related]
9. Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topic.
Laprais A; Olivry T
BMC Vet Res; 2017 Feb; 13(1):61. PubMed ID: 28222789
[TBL] [Abstract][Full Text] [Related]
10. Hemorrhagic diathesis and bone marrow aplasia secondary to lomustine overdose in a dog.
Henker LC; Kemper RT; Bianchi SP; Bandinelli MB; Pavarini SP
Vet Clin Pathol; 2019 Jun; 48(2):255-258. PubMed ID: 31062418
[TBL] [Abstract][Full Text] [Related]
11. Lomustine chemotherapy for the treatment of presumptive haemophagocytic histiocytic sarcoma in Flat-coated Retrievers.
Elliott J
Aust Vet J; 2018 Dec; 96(12):502-507. PubMed ID: 30478839
[TBL] [Abstract][Full Text] [Related]
12. Toxicity of metronomic cyclophosphamide chemotherapy in a UK population of cancer-bearing dogs: a retrospective study.
Harper A; Blackwood L
J Small Anim Pract; 2017 Apr; 58(4):227-230. PubMed ID: 28133740
[TBL] [Abstract][Full Text] [Related]
13. Safety evaluation of combination CCNU and continuous toceranib phosphate (Palladia(®) ) in tumour-bearing dogs: a phase I dose-finding study.
Pan X; Tsimbas K; Kurzman ID; Vail DM
Vet Comp Oncol; 2016 Jun; 14(2):202-9. PubMed ID: 24735385
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the risks of chemotherapy in dogs with thrombocytopenia.
Finlay J; Wyatt K; Black M
Vet Comp Oncol; 2017 Mar; 15(1):151-162. PubMed ID: 25864417
[TBL] [Abstract][Full Text] [Related]
15. Multiple cutaneous histiocytomas treated with lomustine in a dog.
Maina E; Colombo S; Stefanello D
Vet Dermatol; 2014 Dec; 25(6):559-62, e98-9. PubMed ID: 24963782
[TBL] [Abstract][Full Text] [Related]
16. Recovery from Cyclophosphamide Overdose in a Dog.
Finlay JR; Wyatt K; North C
J Am Anim Hosp Assoc; 2017; 53(4):230-235. PubMed ID: 28535135
[TBL] [Abstract][Full Text] [Related]
17. Carboplatin-induced myelosuppression as related to body weight in dogs.
Coffee C; Roush JK; Higginbotham ML
Vet Comp Oncol; 2020 Dec; 18(4):804-810. PubMed ID: 32452107
[TBL] [Abstract][Full Text] [Related]
18. Lomustine (CCNU) and prednisone chemotherapy for high-grade completely excised canine mast cell tumors.
Hay JK; Larson VS
Can Vet J; 2019 Dec; 60(12):1326-1330. PubMed ID: 31814640
[TBL] [Abstract][Full Text] [Related]
19. A Retrospective Study of Multi-agent Chemotherapy including either Cyclophosphamide or Lomustine as Initial Therapy for Canine High-grade T-cell Lymphoma (2011-2017).
Elliott J; Baines S
Aust Vet J; 2019 Sep; 97(9):308-315. PubMed ID: 31328256
[TBL] [Abstract][Full Text] [Related]
20. Retrospective comparison of three doses of metronomic chlorambucil for tolerability and efficacy in dogs with spontaneous cancer.
Custead MR; Weng HY; Childress MO
Vet Comp Oncol; 2017 Sep; 15(3):808-819. PubMed ID: 27136377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
